We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Challenge to Industry Settlement Strategy Likely to Fail
FTC Challenge to Industry Settlement Strategy Likely to Fail
May 5, 2006
The FTC’s pledge to challenge the constitutionality of brand name drug companies’ strategy of paying generic manufacturers to drop patent-infringement suits is likely to fail, PhRMA President Billy Tauzin told WDL.